chloroquine has been researched along with tinidazole in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 7 (43.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Knight, R | 1 |
| Wolfe, MS | 1 |
| Bru, C; Corachán, M; García-Forcada, A; Gascón, J; Sans, M; Valls, ME | 1 |
| Dioka, CE; Nwobodo, EO; Ofoefule, SI; Orisakwe, OE; Ufearo, CS | 1 |
| Almirall, P; Escobedo, AA; Moreira, I; Núñez, FA; Pareja, A; Vega, E | 1 |
| Bennett, K; Deye, GA; Fracisco, S; Gettayacamin, M; Hansukjariya, P; Im-erbsin, R; Macareo, L; Magill, AJ; Ohrt, C; Rothstein, Y; Sattabongkot, J | 1 |
| Cheah, PY; Lwin, KM; Macareo, L; Miller, RS; Nosten, F; Yuentrakul, P | 1 |
| Carter, ER; Chiodini, PL; Hedley, L; Nabarro, LE | 1 |
| Almirall, P; Ballesteros, J; Escobedo, AA; González-Fraile, E | 1 |
4 review(s) available for chloroquine and tinidazole
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The treatment of intestinal protozoan infections.
Topics: Amebicides; Antimalarials; Antiprotozoal Agents; Balantidiasis; Chloroquine; Coccidiosis; Dientamoebiasis; Drug Combinations; Dysentery, Amebic; Emetine; Furans; Furazolidone; Giardiasis; Humans; Intestinal Diseases, Parasitic; Iodoquinol; Liver Abscess, Amebic; Metronidazole; Paromomycin; Quinacrine; Sulfamethoxazole; Tetracycline; Tinidazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1982 |
Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions.
Topics: Albendazole; Antiprotozoal Agents; Chloroquine; Drug Resistance; Drug Therapy, Combination; Giardia lamblia; Giardiasis; Humans; Metronidazole; Quinacrine; Tinidazole; Treatment Failure | 2018 |
Efficacy of 5-nitroimidazole compounds for giardiasis in Cuban children: systematic review and meta-analysis.
Topics: Antiprotozoal Agents; Benzimidazoles; Child; Chloroquine; Cuba; Giardiasis; Humans; Nitro Compounds; Nitroimidazoles; Paromomycin; Randomized Controlled Trials as Topic; Thiazoles; Tinidazole; Treatment Outcome | 2019 |
2 trial(s) available for chloroquine and tinidazole
| Article | Year |
|---|---|
Comparison of chloroquine, albendazole and tinidazole in the treatment of children with giardiasis.
Topics: Adolescent; Albendazole; Antiprotozoal Agents; Child; Child, Preschool; Chloroquine; Feces; Female; Giardiasis; Humans; Male; Tinidazole; Treatment Outcome | 2003 |
Triangular test design to evaluate tinidazole in the prevention of Plasmodium vivax relapse.
Topics: Adult; Antimalarials; Chemoprevention; Chloroquine; Drug Therapy, Combination; Female; Humans; Malaria, Vivax; Male; Myanmar; Parasite Load; Parasitemia; Secondary Prevention; Thailand; Tinidazole; Treatment Outcome | 2013 |
10 other study(ies) available for chloroquine and tinidazole
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
The chemotherapy of amoebiasis.
Topics: Acetanilides; Amebiasis; Amebicides; Arsenicals; Carrier State; Chloroquine; Dysentery, Amebic; Emetine; Entamoebiasis; Erythromycin; Furans; Humans; Hydroxyquinolines; Metronidazole; Nitroimidazoles; Paromomycin; Tetracyclines; Tinidazole | 1980 |
[Amebic liver abscess: review of 13 cases].
Topics: Adult; Age Factors; Amebicides; Chloroquine; Drug Therapy, Combination; Emetine; Female; Humans; Liver Abscess, Amebic; Male; Metronidazole; Middle Aged; Sex Factors; Spain; Tinidazole | 1995 |
Carbon black (N220): a possible role in poison management.
Topics: Administration, Oral; Adsorption; Animals; Carbon; Carcinogens; Chloroquine; Metronidazole; Mice; Poisoning; Tinidazole | 1995 |
Use of a rhesus Plasmodium cynomolgi model to screen for anti-hypnozoite activity of pharmaceutical substances.
Topics: Animals; Antimalarials; Chloroquine; Disease Models, Animal; Drug Evaluation, Preclinical; Macaca mulatta; Malaria, Vivax; Parasitemia; Plasmodium cynomolgi; Plasmodium vivax; Primaquine; Pyrazinamide; Secondary Prevention; Sporozoites; Tinidazole; Triamterene | 2012 |